Association of Alterations in ParC and GyrA Proteins with Resistance of Clinical Isolates of Enterococcus faecium to Nine Different Fluoroquinolones

Similar Items

• Comparative In Vitro Activities of Ciprofloxacin, Clinafloxacin, Gatifloxacin, Levofloxacin, Moxifloxacin, and Trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes Clinical Isolates with Alterations in GyrA and ParC Proteins
  od: Brisse, Sylvain, i dr.
  Izdano: (1999)
• Alterations in GyrA and ParC Associated with Fluoroquinolone Resistance in Enterococcus faecium
  od: el Amin, Nagwa, i dr.
  Izdano: (1999)
• Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season
  od: Jones, Mark E., i dr.
  Izdano: (2000)
• In Vitro Activities of Sitafloxacin (DU-6859a) and Six Other Fluoroquinolones against 8,796 Clinical Bacterial Isolates
  od: Milatovic, Dana, i dr.
  Izdano: (2000)
• Characterization of grlA, grlB, gyrA, and gyrB Mutations in 116 Unrelated Isolates of Staphylococcus aureus and Effects of Mutations on Ciprofloxacin MIC
  od: Schmitz, Franz-Josef, i dr.
  Izdano: (1998)